January 25th 2012 | Biologics, Patient Stories, Psoriasis Cure Now, Psoriasis Research, Public policy issues, psoriatic arthritis | 4 Comments
Before 2011 becomes a distant memory, Psoriasis Cure Now felt it would be useful to highlight what we believe were the top psoriasis and psoriatic arthritis stories of 2011. The year included bad news about a promising treatment from Abbott, as well as a psoriasis sub-plot to one of the more ridiculous media sensations
READ THE FULL POST
July 22nd 2011 | Impact of psoriasis, Patient Stories | 4 Comments
Get the latest on Kim Kardashian and her psoriasis diagnosis here.
March 2nd 2011 | Biologics, Health care system, Public policy issues, psoriatic arthritis | 1 Comment
We’re happy to see the Phil Mickelson psoriasis, psoriatic arthritis, and RA campaign launch. Go Phil! We hope he is winning again soon.
The campaign is called On Course with Phil, and you can see the site here: http://www.oncoursewithphil.com .
The campaign is owned by Amgen & Pfizer (they market the popular biologic Enbrel [etanercept]). Our only
READ THE FULL POST
February 16th 2011 | Get involved, Psoriasis Cure Now, Psoriasis Research, Public policy issues | 2 Comments
The US Government, through the National Institutes of Health (NIH), maintained in 2010 its record level of research funding for psoriasis and psoriatic arthritis. The total was $16 million, as it was in 2009. As recently as 2005 the total was just $5 million.
Progress!
Read more about research funding for psoriasis and psoriatic arthritis.
February 10th 2011 | Alternative/buyer beware/natural, Health care system, Public policy issues, Treatment | 7 Comments
Are you paying too much for nonprescription psoriasis treatments? Many psoriasis patients are paying WAY too much for 2% coal tar and other common psoriasis treatments.
Post a comment below or email us [ info@psoriasis-cure-now.org ] with your most expensive NON-prescription meds; we’re going to start calling out these overpriced products and their doctor and nonprofit
READ THE FULL POST
January 24th 2011 | Patient Stories | 0 Comments
Too bizarre to make up?
Lead singer Liam Gallagher of Oasis — one of the great (if currently-disbanded) rock bands of our time — recently disclosed he has severe psoriasis as part of a strange anecdote recounted by the Sun tabloid in the UK:
“I’ve got psoriasis all over my [expletive deleted] body. Everywhere except for me
READ THE FULL POST
January 19th 2011 | Biologics, Psoriasis Research, Treatment | 0 Comments
Even treatments that are already approved by the U.S. Food and Drug Administration (FDA) are frequently tested further in clinical trials under close medical supervision. Such trials typically offer free meds and thorough medical screening – a great deal for patients. Check out our full report on psoriasis research studies for FDA-approved treatments.
With more
READ THE FULL POST
January 15th 2011 | Biologics, Psoriasis Research, Side-effects of treatment | 13 Comments
Abbott today announced in a securities filing that it has withdrawn its application with the U.S. Food and Drug Administration (FDA) and European regulators to market its much-anticipated, experimental psoriasis treatment briakinumab (ABT-874, Ozespa). The biologic, like Centocor Ortho Biotech’s Stelara (ustekinumab), targets two internal proteins linked to inflammation, IL-12 and IL-23. Briakinumab
READ THE FULL POST
